title: Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center.
abstract: BACKGROUND
  New recommendations concerning the use of prophylactic anticoagulation for medically ill patients have been in use for some time now. This study aims at assessing how much house-staff in a tertiary care setting are implementing these new recommendations in the hope that through quantitative analysis of the deficiency we would be able to identify areas of weakness.
  
  
  METHODS
  About 250 patients were randomly selected from all patients admitted to the American University of Beirut Medical Center (AUBMC) during the year 2005 and stayed more than 48 h. The risk factor profiles, contraindications to thromboprophylaxis, if present, and whether these patients received the appropriate VTE pharmacologic prophylaxis during their stay in hospital were recorded.
  
  
  RESULTS
  About 139 patients were found to have two or more risk factors, with no absolute contraindications. About 37 patients (26.6%) received VTE prophylaxis. Upon reviewing the risk factors profile, the majority of patients (71.3%) were found to have 2-4 risk factors. Among risk factors studied, age > 40 years, admission to ICU, prior VTE, chronic lung disease, infection, respiratory failure, and central venous catheter were significantly associated with receiving prophylaxis.
  
  
  CONCLUSIONS
  VTE prophylaxis is underutilized at AUBMC, a tertiary care teaching hospital in the Middle East. Critical care patients were being acceptably anti-coagulated, whereas cancer patients are doing the worst.
authors: Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon.
authors: Ramy
authors: R
authors: Masroujeh
authors: Wael
authors: W
authors: Shamseddeen
authors: Hussain
authors: H
authors: Isma'eel
authors: Zaher K
authors: ZK
authors: Otrock
authors: Ismail M
authors: IM
authors: Khalil
authors: Ali
authors: A
authors: Taher
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D004363:Drug Utilization; D005260:Female; D019983:Guideline Adherence; D006784:Hospitals, Teaching; D006801:Humans; D007297:Inpatients; D007861:Lebanon; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D055815:Young Adult
chemical_list: D000925:Anticoagulants
references: Thromb Haemost. 2005 Oct;94(4):750-9
references: 16270626
references: Curr Opin Pulm Med. 2001 Sep;7(5):332-7
references: 11584185
references: Blood Coagul Fibrinolysis. 1999 Aug;10 Suppl 2:S45-51
references: 10493230
references: Semin Thromb Hemost. 1991;17 Suppl 3:313-8
references: 1754887
references: Semin Thromb Hemost. 2002 Dec;28(6):577-84
references: 12536351
references: Thromb Res. 2003;111(4-5):215-9
references: 14693166
references: J Coll Physicians Surg Pak. 2004 Apr;14(4):211-4
references: 15228823
references: Chest. 2004 Sep;126(3 Suppl):338S-400S
references: 15383478
references: Haematologica. 2002 Jul;87(7):746-50; discussion 250
references: 12091126
references: Semin Hematol. 2001 Apr;38(2 Suppl 5):12-9
references: 11449339
references: J R Soc Med. 2005 Nov;98(11):507-12
references: 16260800
references: Ann Pharmacother. 2004 Jan;38(1):36-40
references: 14742790
references: ANZ J Surg. 2002 May;72(5):331-4
references: 12028089